Evidence map›Paper›PMID 41171871›Full record

ArticleMicrobial genomics2025

Biodiscovery of

Lorena Rodríguez-Orduña, César Aguilar, Alan Gerardo Hernández-Melgar, Héctor F Arocha Garza, Karina Verdel-Aranda, Augusto Vázquez Rodríguez, José L López-Ribot, Aldo Moreno-Ulloa, Cuauhtémoc Licona-Cassani

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Lorena Rodríguez-OrduñaTecnológico de Monterrey, Industrial Genomics Laboratory, Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Monterrey, N.L., Mexico.
César AguilarTecnológico de Monterrey, Industrial Genomics Laboratory, Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Monterrey, N.L., Mexico.
Alan Gerardo Hernández-MelgarBiomedical Innovation Department, CICESE, Ensenada, B.C., Mexico.
Héctor F Arocha GarzaGenesis Laboratory, Cuatro Ciénegas de Carranza, Coahuila, Mexico.
Karina Verdel-ArandaTecnológico Nacional de México, Instituto Tecnológico de Chiná, Chiná, Campeche, Mexico.
Augusto Vázquez RodríguezDepartment of Molecular Microbiology and Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, USA.
José L López-RibotDepartment of Molecular Microbiology and Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, USA.
Aldo Moreno-UlloaBiomedical Innovation Department, CICESE, Ensenada, B.C., Mexico.
Cuauhtémoc Licona-CassaniTecnológico de Monterrey, Industrial Genomics Laboratory, Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Monterrey, N.L., Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discovery of novel bioactive natural products from

Indexed as

ActinobacteriaMetabolomicsNocardiaStreptomycesBiological ProductsBiosynthetic PathwaysEcosystemGenome, BacterialGenomicsMexicoMultigene FamilySoil MicrobiologyBiological ProductsActinomycetotagenome miningmetabolo-genomicsnatural productsNocardiaStreptomyces

Identifiers

PMID41171871
PMCPMC13293302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.